News Image

GILEAD SCIENCES (NASDAQ: GILD) Breakout Swing Trading Idea

By Kristoff De Turck

Last update: Aug 16, 2022

TRADING IDEA (Momentum Swing Trading Breakout)

Gilead Sciences, Inc. is a biopharmaceutical company, which engages in the research, development, and commercialization of medicines in areas of unmet medical need. Read the full profile here.

STRATEGY

Breakout Swing Trading Idea

  1. clean breakout during last trading session, wide range bullish bar closed near the high of day (+5.2%)
  2. strongly increased buying volume
  3. closing price above current daily resistance level
  4. long term trend (weekly chart), price breakout above sideways trading channel

Last earnings: 2022-08-02

Next earnings: 2022-10-26



ACTUAL SETUP

  • Buy Stop | $66.36
  • Limit | $66.50
  • Stoploss | $63.44
  • Target | first and second target area on weekly chart

ADDITIONAL INFO/TIPS

Disclaimer: These trading ideas are merely to demonstrate what ChartMill is capable of and shows some typical results of a breakout filter. It is in no way actual financial advise to invest or trade in these stocks. The author has no pre-existing position in any of these stocks.

Back

GILEAD SCIENCES INC

NASDAQ:GILD (5/3/2024, 7:00:01 PM)

After market: 64.79 +0.01 (+0.02%)

64.78

-0.55 (-0.84%)

GILD News

News Imagea day ago - Market News VideoNasdaq 100 Movers: FTNT, AMGN
News Imagea day ago - Market News VideoInteresting GILD Put And Call Options For June 14th
News Imagea day ago - The Business JournalsGilead cuts jobs, trims drugs amid deeper biopharma pullback
News Image3 days ago - InvestorPlaceShhh! 3 Secret Biotech Stocks Flying Below Wall Street’s Radar

These biotech stocks seem to be rich with intriguing growth plays going for very reasonable multiples this May.

News Image4 days ago - Gilead Sciences, Inc.Gilead Sciences to Present at Upcoming Investor Conferences
News Image5 days ago - Zacks Investment ResearchGilead Sciences, Inc. (GILD) Is a Trending Stock: Facts to Know Before Betting on It

Gilead (GILD) has received quite a bit of attention from Zacks.com users lately. Therefore, it is wise to be aware of the facts that can impact the stock's prospects.

News Image6 days ago - New York TimesU.S. Lags Behind Other Countries in Hepatitis-C Treatment

Despite an arsenal of drugs, many Americans are still unaware of their infections until it’s too late. A Biden initiative languishes without Congressional approval.

News Image8 days ago - Market News VideoJune 7th Options Now Available For Gilead Sciences (GILD)
News Image8 days ago - InvestorPlace3 Dividend Stocks to Buy at a 52-Week Low in April

Explore these three dividend stocks trading near their 52-week lows, presenting compelling opportunities for income-oriented investors.

News Image8 days ago - Gilead Sciences, Inc.FDA Approves Biktarvy® Label Update With Data for Pregnant Adults With HIV
News Image9 days ago - ChartmillCurious about which S&P500 stocks are showing activity after the closing bell on Thursday?

Let's have a look at what is happening on the US markets after the closing bell on Thursday. Below you can find the top S&P500 gainers and losers in today's after hours session.

News Image17 days ago - ChartmillWhy the dividend investor may take a look at NASDAQ:GILD.

Uncovering Dividend Opportunities with GILEAD SCIENCES INC (NASDAQ:GILD).

GILD Links
Follow us for more